Cancer can leave lasting physical and psychological effects on patients, even after treatment. Jinko, a pioneering start-up, is stepping up to fill the gap with personalized supportive care, raising €2M in funding to accelerate its mission.
- Major Investment: Jinko has raised €2M in a funding round led by 360 Capital, along with AFI Ventures and 10 business angels from the medical and pharmaceutical sectors.
- Comprehensive Supportive Care: Jinko offers a holistic care approach, including psychological support, dietary counseling, physical activities, and more, tailored to each patient’s needs.
- Proven Benefits: Supportive care reduces mortality, recurrences, and treatment side effects, with over 80% of cancer patients experiencing ongoing effects post-treatment.
- Affordable Care Goal: Jinko aims to make supportive care more accessible, with a long-term vision to provide free services to all in need.
Jinko is transforming cancer care by addressing the often-overlooked supportive care needs of patients. With their personalized, tech-driven approach, they are set to make a meaningful impact on the lives of those recovering from cancer
